MedTech Company Portal Diabetes to Relocate HQ to Westfield

Westfield, IN (September 24, 2024) — Portal Diabetes Inc. (“Portal”), a medical technology company, announced plans to relocate their headquarters to Westfield from Southern California on Monday evening. As part of its relocation, the company is also announcing a name change from PhysioLogic Devices, Inc. and their technology called ThinPump to Portal Diabetes Inc. and the Portal Pump.

Founded in 2013, Portal is developing a fully automatic, implantable insulin pump to control glucose levels. Its Portal Pump technology will be the first fully automated insulin delivery system that can store up to 12 weeks of insulin through an artificial pancreas.

We are thrilled that Portal has chosen to relocate their headquarters to Westfield. They are on the cutting edge of transforming the lives of diabetics across the globe and will make a great corporate partner in our community. Their capital investment and high paying jobs align perfectly with my long-term vision of creating a high technology manufacturing center in Westfield with an emphasis in the biotechnology and healthcare space,” stated Mayor Scott Willis.

Click here to read the full text.